Kinaxis to bring concurrent planning to leading global manufacturer and distributor of medical and laboratory products.
OTTAWA, CANADA, Feb. 9, 2022 – Kinaxis® Inc. (TSX:KXS), the authority in driving agility for fast, confident decision-making in an unpredictable world, announced today that Cardinal Health has selected Kinaxis to increase medical product visibility and delivery through improved supply chain agility.
Kinaxis will enhance Cardinal Health’s medical supply chain through concurrent planning and end-to-end network visibility and transparency. With Kinaxis, Cardinal Health can factor in seasonality and pandemic planning, instantly balance demand and supply while accounting for capacity safeguards and simulate product supply scenarios in seconds to create best-fit solutions for its customers. The Kinaxis RapidResponse® platform supports fast, confident decisions using advanced insights and analytics in real time.
Cardinal Health will focus on initial implementation efforts of Kinaxis RapidResponse within the Cardinal Health at-Home Solutions business, the largest direct-to-home supplier of disposable medical supplies, with an expected completion date of Summer 2022. A full implementation of the RapidResponse platform across the Cardinal Health medical business is anticipated for completion by the end of the calendar year 2023.
“Integrating Kinaxis RapidResponse allows us to view our entire supply chain in real time to proactively mitigate and minimize potential impacts to our customers – and ultimately, their patients,” said Paul Rodio, SVP Global Planning at Cardinal Health. “Kinaxis is a key enabler to driving optimization in our end-to-end global planning process”
With the addition of RapidResponse, Cardinal Health will standardize medical planning within one platform, further improving overall planning, supplier management, risk management and inventory capabilities.
“Concurrent planning is becoming critical for the medical industry. Being able to monitor risks, adapt quickly and react to change in real time means people get their medical needs met, even if there’s disruption. Kinaxis RapidResponse is the world’s first and only concurrent planning platform,” said John Sicard, Kinaxis CEO. “We’re excited to collaborate with Cardinal Health to bring this advanced planning to healthcare customers and increase accessibility to the products they need most.”
About Kinaxis Inc.
Everyday volatility and uncertainty demand quick action. Kinaxis® delivers the agility to make fast, confident decisions across integrated business planning and the digital supply chain. People can plan better, live better and change the world. Trusted by innovative brands, we combine human intelligence with AI and concurrent planning to help companies plan for any future, monitor risks and opportunities and respond at the pace of change. Powered by an extensible, cloud-based platform, Kinaxis delivers industry-proven applications so everyone can know sooner, act faster and remove waste. For more Kinaxis news, visit Kinaxis.com or follow us on LinkedIn or Twitter.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to Kinaxis' growth opportunities and the potential benefits of, and demand for, Kinaxis’ products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis' products and services compared to competitive offerings in the industry. Readers are cautioned not to place undue reliance on such statements. Kinaxis' actual results, performance, achievements and developments may differ materially from the results, performance, achievements or developments expressed or implied by such statements. Risk factors that may cause the actual results, performance, achievements or developments of Kinaxis to differ materially from the results, performance, achievements or developments expressed or implied by such statements can be found in the public documents filed by Kinaxis with Canadian securities regulatory authorities. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.
Jaime Cook | Kinaxis
Rick Wadsworth | Kinaxis